Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first?

about

Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first?

Item

http://www.wikidata.org/entity/Q58797711

description

scientific article published on 07 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Synchronous liver metastases i ...... tablish which treatment first?

@en

Synchronous liver metastases i ...... tablish which treatment first?

@nl

type

Item

label

Synchronous liver metastases i ...... tablish which treatment first?

@en

Synchronous liver metastases i ...... tablish which treatment first?

@nl

prefLabel

Synchronous liver metastases i ...... tablish which treatment first?

@en

Synchronous liver metastases i ...... tablish which treatment first?

@nl

P1476

Synchronous liver metastases i ...... tablish which treatment first?

@en

P2093

Per Pfeiffer

http://www.w3.org/2001/XMLSchema#string

Robert Glynne-Jones

http://www.w3.org/2001/XMLSchema#string

Thomas Gruenberger

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial

Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer

Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.

P304

1758835918787993

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1177/1758835918787993

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Per Pfeiffer

T Gruenberger

Rob Glynne-Jones

P577

2018-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30093921

http://www.w3.org/2001/XMLSchema#string

P932

6081759

http://www.w3.org/2001/XMLSchema#string